

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | urate metabolic process (GO:0046415) | 9.53342726 |
| 2 | protein-chromophore linkage (GO:0018298) | 9.51038324 |
| 3 | aminoglycoside antibiotic metabolic process (GO:0030647) | 9.25977424 |
| 4 | drug transmembrane transport (GO:0006855) | 8.72200694 |
| 5 | detection of light stimulus involved in visual perception (GO:0050908) | 8.38039493 |
| 6 | detection of light stimulus involved in sensory perception (GO:0050962) | 8.38039493 |
| 7 | cellular response to electrical stimulus (GO:0071257) | 7.74160926 |
| 8 | drug transport (GO:0015893) | 7.24566596 |
| 9 | organic cation transport (GO:0015695) | 7.05789174 |
| 10 | actin filament depolymerization (GO:0030042) | 6.94163371 |
| 11 | phosphate ion transport (GO:0006817) | 6.74990255 |
| 12 | response to mercury ion (GO:0046689) | 6.17893531 |
| 13 | lysine metabolic process (GO:0006553) | 6.14010960 |
| 14 | lysine catabolic process (GO:0006554) | 6.14010960 |
| 15 | collecting duct development (GO:0072044) | 6.09376119 |
| 16 | drug catabolic process (GO:0042737) | 5.59737922 |
| 17 | cardiovascular system development (GO:0072358) | 5.49014131 |
| 18 | phosphate ion transmembrane transport (GO:0035435) | 5.44156328 |
| 19 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 5.42470397 |
| 20 | exogenous drug catabolic process (GO:0042738) | 5.42191855 |
| 21 | renal absorption (GO:0070293) | 5.41208451 |
| 22 | fat-soluble vitamin metabolic process (GO:0006775) | 5.34307579 |
| 23 | excretion (GO:0007588) | 5.32533836 |
| 24 | sodium-independent organic anion transport (GO:0043252) | 5.32411071 |
| 25 | glyoxylate metabolic process (GO:0046487) | 5.20022287 |
| 26 | cell volume homeostasis (GO:0006884) | 5.15967212 |
| 27 | vitamin transmembrane transport (GO:0035461) | 5.06867858 |
| 28 | retinal metabolic process (GO:0042574) | 5.05684206 |
| 29 | rhodopsin mediated signaling pathway (GO:0016056) | 4.97533066 |
| 30 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.87783771 |
| 31 | phototransduction, visible light (GO:0007603) | 4.76488467 |
| 32 | * quaternary ammonium group transport (GO:0015697) | 4.74542670 |
| 33 | tricarboxylic acid metabolic process (GO:0072350) | 4.71506209 |
| 34 | positive regulation of catenin import into nucleus (GO:0035413) | 4.71200255 |
| 35 | response to water (GO:0009415) | 4.70344530 |
| 36 | short-chain fatty acid metabolic process (GO:0046459) | 4.64428599 |
| 37 | phototransduction (GO:0007602) | 4.64030590 |
| 38 | metanephric tubule development (GO:0072170) | 4.62177881 |
| 39 | metanephric nephron tubule development (GO:0072234) | 4.62177881 |
| 40 | phosphate ion homeostasis (GO:0055062) | 4.59946970 |
| 41 | trivalent inorganic anion homeostasis (GO:0072506) | 4.59946970 |
| 42 | vitamin D metabolic process (GO:0042359) | 4.56707027 |
| 43 | cell-cell junction maintenance (GO:0045217) | 4.54494105 |
| 44 | cysteine metabolic process (GO:0006534) | 4.48161527 |
| 45 | retinol metabolic process (GO:0042572) | 4.46484512 |
| 46 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 4.45524075 |
| 47 | endothelium development (GO:0003158) | 4.42865869 |
| 48 | metanephric nephron epithelium development (GO:0072243) | 4.42610554 |
| 49 | detection of light stimulus (GO:0009583) | 4.37894566 |
| 50 | response to lead ion (GO:0010288) | 4.32385177 |
| 51 | detection of visible light (GO:0009584) | 4.31211655 |
| 52 | response to thyroid hormone (GO:0097066) | 4.29126065 |
| 53 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.29023649 |
| 54 | lymph vessel development (GO:0001945) | 4.28413078 |
| 55 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 4.28407242 |
| 56 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.27159680 |
| 57 | gamma-aminobutyric acid transport (GO:0015812) | 4.19631272 |
| 58 | vitamin transport (GO:0051180) | 4.14132070 |
| 59 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 4.13576889 |
| 60 | metanephric epithelium development (GO:0072207) | 4.11050078 |
| 61 | aspartate family amino acid catabolic process (GO:0009068) | 4.08582941 |
| 62 | toxin transport (GO:1901998) | 4.06087406 |
| 63 | regulation of guanylate cyclase activity (GO:0031282) | 3.97951793 |
| 64 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.97317012 |
| 65 | branched-chain amino acid metabolic process (GO:0009081) | 3.97266396 |
| 66 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.94871793 |
| 67 | negative regulation of sterol transport (GO:0032372) | 3.94256536 |
| 68 | negative regulation of cholesterol transport (GO:0032375) | 3.94256536 |
| 69 | surfactant homeostasis (GO:0043129) | 3.91520875 |
| 70 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.91371910 |
| 71 | homocysteine metabolic process (GO:0050667) | 3.88667034 |
| 72 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 3.88610181 |
| 73 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.87129933 |
| 74 | cell junction maintenance (GO:0034331) | 3.81412185 |
| 75 | negative regulation of metanephros development (GO:0072217) | 3.81019724 |
| 76 | amino-acid betaine transport (GO:0015838) | 3.79720006 |
| 77 | carnitine transport (GO:0015879) | 3.79720006 |
| 78 | nephron tubule development (GO:0072080) | 3.77300992 |
| 79 | glutathione biosynthetic process (GO:0006750) | 3.73112708 |
| 80 | polyol transport (GO:0015791) | 3.70492322 |
| 81 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.69672618 |
| 82 | L-phenylalanine metabolic process (GO:0006558) | 3.69672618 |
| 83 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.63307421 |
| 84 | L-phenylalanine catabolic process (GO:0006559) | 3.63307421 |
| 85 | response to copper ion (GO:0046688) | 3.62914183 |
| 86 | glycoside metabolic process (GO:0016137) | 3.62246458 |
| 87 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.62186020 |
| 88 | valine metabolic process (GO:0006573) | 3.61577496 |
| 89 | aromatic amino acid family catabolic process (GO:0009074) | 3.60809694 |
| 90 | retinoid metabolic process (GO:0001523) | 3.59776055 |
| 91 | visual perception (GO:0007601) | 3.56282356 |
| 92 | proline metabolic process (GO:0006560) | 3.54929395 |
| 93 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.53832209 |
| 94 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 3.53333814 |
| 95 | sensory perception of light stimulus (GO:0050953) | 3.52109099 |
| 96 | cellular modified amino acid catabolic process (GO:0042219) | 3.51393333 |
| 97 | nephron epithelium development (GO:0072009) | 3.49322616 |
| 98 | tryptophan catabolic process (GO:0006569) | 3.46430420 |
| 99 | indole-containing compound catabolic process (GO:0042436) | 3.46430420 |
| 100 | indolalkylamine catabolic process (GO:0046218) | 3.46430420 |
| 101 | * modified amino acid transport (GO:0072337) | 3.43352200 |
| 102 | renal system process (GO:0003014) | 3.42648249 |
| 103 | short-term memory (GO:0007614) | 3.41205988 |
| 104 | fatty acid beta-oxidation (GO:0006635) | 3.37418858 |
| 105 | diterpenoid metabolic process (GO:0016101) | 3.35785807 |
| 106 | cellular response to vitamin D (GO:0071305) | 3.33570315 |
| 107 | keratan sulfate catabolic process (GO:0042340) | 3.32428761 |
| 108 | branched-chain amino acid catabolic process (GO:0009083) | 3.29876331 |
| 109 | renal tubule development (GO:0061326) | 3.28018397 |
| 110 | positive regulation of ERBB signaling pathway (GO:1901186) | 3.27143249 |
| 111 | fructose metabolic process (GO:0006000) | 3.26521187 |
| 112 | serine family amino acid catabolic process (GO:0009071) | 3.26001295 |
| 113 | nephron tubule formation (GO:0072079) | 3.25258981 |
| 114 | tryptophan metabolic process (GO:0006568) | 3.25222148 |
| 115 | Notch signaling involved in heart development (GO:0061314) | 3.25166690 |
| 116 | detection of external stimulus (GO:0009581) | 3.21850284 |
| 117 | inositol metabolic process (GO:0006020) | 3.21260803 |
| 118 | cellular ketone body metabolic process (GO:0046950) | 3.19451252 |
| 119 | oligosaccharide catabolic process (GO:0009313) | 3.19132416 |
| 120 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.17230890 |
| 121 | response to parathyroid hormone (GO:0071107) | 3.17088313 |
| 122 | amino-acid betaine metabolic process (GO:0006577) | 3.16020829 |
| 123 | amine catabolic process (GO:0009310) | 3.10630583 |
| 124 | cellular biogenic amine catabolic process (GO:0042402) | 3.10630583 |
| 125 | peptide biosynthetic process (GO:0043043) | 3.10057564 |
| 126 | detection of abiotic stimulus (GO:0009582) | 3.10002621 |
| 127 | chemical homeostasis within a tissue (GO:0048875) | 3.09575920 |
| 128 | nephron epithelium morphogenesis (GO:0072088) | 3.08691758 |
| 129 | nephron tubule morphogenesis (GO:0072078) | 3.08691758 |
| 130 | bone remodeling (GO:0046849) | 3.08496629 |
| 131 | * sulfur compound transport (GO:0072348) | 3.08341004 |
| 132 | sodium ion transport (GO:0006814) | 3.06150110 |
| 133 | hyperosmotic response (GO:0006972) | 3.05764850 |
| 134 | fatty acid oxidation (GO:0019395) | 3.05616685 |
| 135 | cellular potassium ion homeostasis (GO:0030007) | 3.05254700 |
| 136 | regulation of catenin import into nucleus (GO:0035412) | 3.03528655 |
| 137 | glutamate metabolic process (GO:0006536) | 3.01987345 |
| 138 | lipid oxidation (GO:0034440) | 3.00203621 |
| 139 | serine family amino acid metabolic process (GO:0009069) | 2.99758064 |
| 140 | regulation of protein localization to cell surface (GO:2000008) | 2.97010099 |
| 141 | response to growth hormone (GO:0060416) | 2.95349080 |
| 142 | glomerular visceral epithelial cell development (GO:0072015) | 2.93351858 |
| 143 | L-ascorbic acid metabolic process (GO:0019852) | 2.90719193 |
| 144 | ERK1 and ERK2 cascade (GO:0070371) | 2.90601668 |
| 145 | response to vitamin A (GO:0033189) | 2.90388634 |
| 146 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.89592150 |
| 147 | terpenoid metabolic process (GO:0006721) | 2.89459601 |
| 148 | carnitine metabolic process (GO:0009437) | 2.89383487 |
| 149 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.88637698 |
| 150 | glutamine family amino acid catabolic process (GO:0009065) | 2.88360919 |
| 151 | response to pheromone (GO:0019236) | 2.87661978 |
| 152 | acetyl-CoA metabolic process (GO:0006084) | 2.87655104 |
| 153 | response to magnesium ion (GO:0032026) | 2.87404971 |
| 154 | response to electrical stimulus (GO:0051602) | 2.86638813 |
| 155 | indole-containing compound metabolic process (GO:0042430) | 2.86270985 |
| 156 | 2-oxoglutarate metabolic process (GO:0006103) | 2.85288757 |
| 157 | renal tubule morphogenesis (GO:0061333) | 2.83953137 |
| 158 | pattern specification involved in kidney development (GO:0061004) | 2.81464421 |
| 159 | cellular amino acid catabolic process (GO:0009063) | 2.80373179 |
| 160 | beta-amyloid metabolic process (GO:0050435) | 2.78467517 |
| 161 | regulation of cGMP biosynthetic process (GO:0030826) | 2.78385460 |
| 162 | peptide catabolic process (GO:0043171) | 2.77001851 |
| 163 | fatty acid catabolic process (GO:0009062) | 2.76458876 |
| 164 | alpha-amino acid catabolic process (GO:1901606) | 2.73762638 |
| 165 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.67909790 |
| 166 | negative regulation of heart growth (GO:0061117) | 2.67909790 |
| 167 | cellular response to ammonium ion (GO:0071242) | 2.66739875 |
| 168 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2 | 2.58469295 |
| 169 | L-methionine salvage (GO:0071267) | 2.58420749 |
| 170 | L-methionine biosynthetic process (GO:0071265) | 2.58420749 |
| 171 | amino acid salvage (GO:0043102) | 2.58420749 |
| 172 | regulation of cGMP metabolic process (GO:0030823) | 2.56432474 |
| 173 | glomerular epithelial cell development (GO:0072310) | 2.54796884 |
| 174 | neuronal action potential propagation (GO:0019227) | 2.53287837 |
| 175 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.52762200 |
| 176 | vitamin A metabolic process (GO:0006776) | 18.8549123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.22545734 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.02931010 |
| 3 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.82948948 |
| 4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.24228896 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.24132623 |
| 6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.22403629 |
| 7 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.13187207 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.12876407 |
| 9 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.08208820 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.04311315 |
| 11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.01661011 |
| 12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.00787312 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.94654075 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.93522116 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.91197284 |
| 16 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.91103539 |
| 17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.90261242 |
| 18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.88360617 |
| 19 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.88360617 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.87347011 |
| 21 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.79968296 |
| 22 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.79275634 |
| 23 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.77571841 |
| 24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.71385427 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.71111138 |
| 26 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.61479053 |
| 27 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.60277449 |
| 28 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.59292523 |
| 29 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.59138183 |
| 30 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.57018269 |
| 31 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.56018055 |
| 32 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.55542522 |
| 33 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.51506288 |
| 34 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.50663136 |
| 35 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.50492441 |
| 36 | RXR_22108803_ChIP-Seq_LS180_Human | 1.48551155 |
| 37 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.47525546 |
| 38 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.47201416 |
| 39 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.44865298 |
| 40 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.44461610 |
| 41 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.43832367 |
| 42 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.38750080 |
| 43 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.38331047 |
| 44 | VDR_22108803_ChIP-Seq_LS180_Human | 1.37454635 |
| 45 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.37076606 |
| 46 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.33440983 |
| 47 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.31141364 |
| 48 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.30560297 |
| 49 | * CBP_21632823_ChIP-Seq_H3396_Human | 1.29139454 |
| 50 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.28509095 |
| 51 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.27433752 |
| 52 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27292723 |
| 53 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.25246435 |
| 54 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.24697612 |
| 55 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.24258076 |
| 56 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.22528575 |
| 57 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.22507320 |
| 58 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.20422688 |
| 59 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.19358210 |
| 60 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.17586154 |
| 61 | TBL1_22424771_ChIP-Seq_293T_Human | 1.17520658 |
| 62 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.16531358 |
| 63 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.16425306 |
| 64 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16112394 |
| 65 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14921369 |
| 66 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.14149249 |
| 67 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.13839420 |
| 68 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.13816311 |
| 69 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13460199 |
| 70 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.13013741 |
| 71 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.11676963 |
| 72 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.11342578 |
| 73 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.11342575 |
| 74 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.11342575 |
| 75 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10260647 |
| 76 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10158602 |
| 77 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09072618 |
| 78 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08782526 |
| 79 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.08488550 |
| 80 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.08077941 |
| 81 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07079239 |
| 82 | * PHF8_20622853_ChIP-Seq_HELA_Human | 1.06894204 |
| 83 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05305276 |
| 84 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.04426618 |
| 85 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03297127 |
| 86 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.03188138 |
| 87 | NFYA_21822215_ChIP-Seq_K562_Human | 1.02618424 |
| 88 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.01871016 |
| 89 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00498792 |
| 90 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.99513077 |
| 91 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.99329425 |
| 92 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.99249879 |
| 93 | CJUN_26792858_Chip-Seq_BT549_Human | 0.98460733 |
| 94 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.98220512 |
| 95 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.97821854 |
| 96 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.97366387 |
| 97 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97100948 |
| 98 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.96259741 |
| 99 | NFYB_21822215_ChIP-Seq_K562_Human | 0.96249812 |
| 100 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.95673160 |
| 101 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.95472996 |
| 102 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94694681 |
| 103 | STAT3_23295773_ChIP-Seq_U87_Human | 0.94270728 |
| 104 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.94022911 |
| 105 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.93756968 |
| 106 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.93752345 |
| 107 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.93682094 |
| 108 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.93648166 |
| 109 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.93458954 |
| 110 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93421246 |
| 111 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.93366557 |
| 112 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.92874873 |
| 113 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.92839077 |
| 114 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.92311638 |
| 115 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.92183049 |
| 116 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.92107382 |
| 117 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.91777096 |
| 118 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.90478280 |
| 119 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.90348721 |
| 120 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.89576290 |
| 121 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.89554219 |
| 122 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.89432446 |
| 123 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.89245259 |
| 124 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.88853222 |
| 125 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.88674778 |
| 126 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.88674778 |
| 127 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.88375949 |
| 128 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.88326457 |
| 129 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85756012 |
| 130 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.85461428 |
| 131 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.85221874 |
| 132 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.84229901 |
| 133 | AR_25329375_ChIP-Seq_VCAP_Human | 0.81154765 |
| 134 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.79852879 |
| 135 | P300_19829295_ChIP-Seq_ESCs_Human | 0.79673353 |
| 136 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.78882854 |
| 137 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.77591769 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 6.44001597 |
| 2 | MP0005360_urolithiasis | 6.06578268 |
| 3 | MP0004019_abnormal_vitamin_homeostasis | 4.99375322 |
| 4 | MP0005332_abnormal_amino_acid | 4.14017571 |
| 5 | MP0005377_hearing/vestibular/ear_phenot | 3.69507954 |
| 6 | MP0003878_abnormal_ear_physiology | 3.69507954 |
| 7 | MP0001765_abnormal_ion_homeostasis | 3.68906373 |
| 8 | MP0005167_abnormal_blood-brain_barrier | 3.44968399 |
| 9 | MP0003195_calcinosis | 3.43388353 |
| 10 | * MP0009643_abnormal_urine_homeostasis | 3.33443709 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 3.18411870 |
| 12 | MP0002139_abnormal_hepatobiliary_system | 3.10419625 |
| 13 | MP0005636_abnormal_mineral_homeostasis | 3.04687201 |
| 14 | MP0005253_abnormal_eye_physiology | 3.03909462 |
| 15 | MP0001756_abnormal_urination | 2.89928654 |
| 16 | * MP0002136_abnormal_kidney_physiology | 2.63683754 |
| 17 | MP0005551_abnormal_eye_electrophysiolog | 2.54202339 |
| 18 | MP0001986_abnormal_taste_sensitivity | 2.53349050 |
| 19 | MP0004147_increased_porphyrin_level | 2.45167723 |
| 20 | MP0001958_emphysema | 2.37330120 |
| 21 | MP0005423_abnormal_somatic_nervous | 2.35832644 |
| 22 | MP0001879_abnormal_lymphatic_vessel | 2.35656720 |
| 23 | MP0005084_abnormal_gallbladder_morpholo | 2.27953652 |
| 24 | MP0008875_abnormal_xenobiotic_pharmacok | 2.11119045 |
| 25 | MP0003011_delayed_dark_adaptation | 14.5328485 |
| 26 | MP0004885_abnormal_endolymph | 1.99758763 |
| 27 | MP0008961_abnormal_basal_metabolism | 1.81250538 |
| 28 | MP0004484_altered_response_of | 1.73935188 |
| 29 | MP0004272_abnormal_basement_membrane | 1.67299920 |
| 30 | MP0005670_abnormal_white_adipose | 1.59519183 |
| 31 | MP0005085_abnormal_gallbladder_physiolo | 1.56666718 |
| 32 | MP0005365_abnormal_bile_salt | 1.56440138 |
| 33 | MP0003252_abnormal_bile_duct | 1.55411006 |
| 34 | MP0001324_abnormal_eye_pigmentation | 1.54422322 |
| 35 | MP0005165_increased_susceptibility_to | 1.45174081 |
| 36 | MP0000230_abnormal_systemic_arterial | 1.41058844 |
| 37 | MP0010368_abnormal_lymphatic_system | 1.38241763 |
| 38 | MP0005391_vision/eye_phenotype | 1.31208181 |
| 39 | MP0002928_abnormal_bile_duct | 1.29635093 |
| 40 | MP0006138_congestive_heart_failure | 1.23310937 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.22892003 |
| 42 | MP0000538_abnormal_urinary_bladder | 1.22171854 |
| 43 | MP0003186_abnormal_redox_activity | 1.19835406 |
| 44 | MP0005408_hypopigmentation | 1.19633219 |
| 45 | MP0003724_increased_susceptibility_to | 1.18998581 |
| 46 | MP0002090_abnormal_vision | 1.16966763 |
| 47 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14516489 |
| 48 | MP0005058_abnormal_lysosome_morphology | 1.14456383 |
| 49 | MP0001485_abnormal_pinna_reflex | 1.03872781 |
| 50 | MP0003638_abnormal_response/metabolism_ | 1.03092132 |
| 51 | MP0003045_fibrosis | 1.02558982 |
| 52 | MP0005409_darkened_coat_color | 1.00608157 |
| 53 | MP0002896_abnormal_bone_mineralization | 1.00509546 |
| 54 | MP0004742_abnormal_vestibular_system | 0.98028502 |
| 55 | MP0002108_abnormal_muscle_morphology | 0.97186912 |
| 56 | MP0000534_abnormal_ureter_morphology | 0.96360184 |
| 57 | MP0002229_neurodegeneration | 0.94572082 |
| 58 | MP0006072_abnormal_retinal_apoptosis | 0.93928617 |
| 59 | MP0005195_abnormal_posterior_eye | 0.90737472 |
| 60 | MP0003943_abnormal_hepatobiliary_system | 0.90079539 |
| 61 | MP0003879_abnormal_hair_cell | 0.88687096 |
| 62 | MP0002135_abnormal_kidney_morphology | 0.88673459 |
| 63 | MP0005535_abnormal_body_temperature | 0.86117205 |
| 64 | MP0005220_abnormal_exocrine_pancreas | 0.85581694 |
| 65 | MP0002089_abnormal_postnatal_growth/wei | 0.84135652 |
| 66 | MP0002168_other_aberrant_phenotype | 0.82730339 |
| 67 | MP0005595_abnormal_vascular_smooth | 0.81843268 |
| 68 | MP0002876_abnormal_thyroid_physiology | 0.81172235 |
| 69 | MP0003136_yellow_coat_color | 0.79243916 |
| 70 | MP0005623_abnormal_meninges_morphology | 0.78950030 |
| 71 | MP0001873_stomach_inflammation | 0.77708377 |
| 72 | MP0005319_abnormal_enzyme/_coenzyme | 0.76778118 |
| 73 | MP0009764_decreased_sensitivity_to | 0.76395605 |
| 74 | MP0005171_absent_coat_pigmentation | 0.73812746 |
| 75 | MP0003633_abnormal_nervous_system | 0.73736469 |
| 76 | MP0003806_abnormal_nucleotide_metabolis | 0.72670300 |
| 77 | MP0009379_abnormal_foot_pigmentation | 0.69848656 |
| 78 | MP0005395_other_phenotype | 0.66595091 |
| 79 | MP0001764_abnormal_homeostasis | 0.66280470 |
| 80 | MP0001486_abnormal_startle_reflex | 0.64760079 |
| 81 | MP0008004_abnormal_stomach_pH | 0.64178907 |
| 82 | MP0002638_abnormal_pupillary_reflex | 0.63749160 |
| 83 | MP0002098_abnormal_vibrissa_morphology | 0.63584717 |
| 84 | MP0005666_abnormal_adipose_tissue | 0.62053255 |
| 85 | MP0001963_abnormal_hearing_physiology | 0.61089004 |
| 86 | MP0002118_abnormal_lipid_homeostasis | 0.61041380 |
| 87 | MP0009642_abnormal_blood_homeostasis | 0.56724558 |
| 88 | MP0001270_distended_abdomen | 0.56423973 |
| 89 | MP0009278_abnormal_bone_marrow | 0.56023493 |
| 90 | MP0001177_atelectasis | 0.55120104 |
| 91 | MP0010386_abnormal_urinary_bladder | 0.54141400 |
| 92 | MP0006036_abnormal_mitochondrial_physio | 0.53956743 |
| 93 | MP0000678_abnormal_parathyroid_gland | 0.52329256 |
| 94 | MP0004215_abnormal_myocardial_fiber | 0.52262789 |
| 95 | MP0005451_abnormal_body_composition | 0.51335663 |
| 96 | MP0002998_abnormal_bone_remodeling | 0.51229161 |
| 97 | MP0010329_abnormal_lipoprotein_level | 0.50825729 |
| 98 | MP0003690_abnormal_glial_cell | 0.50688528 |
| 99 | MP0002736_abnormal_nociception_after | 0.50380635 |
| 100 | MP0005620_abnormal_muscle_contractility | 0.49957517 |
| 101 | MP0003631_nervous_system_phenotype | 0.49805293 |
| 102 | MP0003959_abnormal_lean_body | 0.49527337 |
| 103 | MP0001664_abnormal_digestion | 0.49227297 |
| 104 | MP0003283_abnormal_digestive_organ | 0.49106622 |
| 105 | MP0002295_abnormal_pulmonary_circulatio | 0.48930409 |
| 106 | MP0002064_seizures | 0.47379952 |
| 107 | MP0002069_abnormal_eating/drinking_beha | 0.47310382 |
| 108 | MP0002115_abnormal_skeleton_extremities | 0.46903867 |
| 109 | MP0001663_abnormal_digestive_system | 0.45403930 |
| 110 | MP0000747_muscle_weakness | 0.44924689 |
| 111 | MP0002735_abnormal_chemical_nociception | 0.44736378 |
| 112 | MP0002752_abnormal_somatic_nervous | 0.44399585 |
| 113 | MP0002734_abnormal_mechanical_nocicepti | 0.44339067 |
| 114 | MP0000920_abnormal_myelination | 0.43559285 |
| 115 | MP0001915_intracranial_hemorrhage | 0.43422708 |
| 116 | MP0002972_abnormal_cardiac_muscle | 0.43147091 |
| 117 | MP0000569_abnormal_digit_pigmentation | 0.42957668 |
| 118 | MP0005275_abnormal_skin_tensile | 0.42695255 |
| 119 | MP0002822_catalepsy | 0.42457486 |
| 120 | MP0002933_joint_inflammation | 0.39975664 |
| 121 | MP0005503_abnormal_tendon_morphology | 0.38731949 |
| 122 | MP0005330_cardiomyopathy | 0.38500883 |
| 123 | MP0001666_abnormal_nutrient_absorption | 0.38357094 |
| 124 | MP0000026_abnormal_inner_ear | 0.38283507 |
| 125 | MP0002272_abnormal_nervous_system | 0.37572883 |
| 126 | MP0001501_abnormal_sleep_pattern | 0.35848473 |
| 127 | MP0008872_abnormal_physiological_respon | 0.35336169 |
| 128 | MP0002075_abnormal_coat/hair_pigmentati | 0.33872135 |
| 129 | MP0004264_abnormal_extraembryonic_tissu | 0.32518050 |
| 130 | MP0003646_muscle_fatigue | 0.30768136 |
| 131 | MP0002882_abnormal_neuron_morphology | 0.25805345 |
| 132 | MP0003634_abnormal_glial_cell | 0.24760927 |
| 133 | MP0002249_abnormal_larynx_morphology | 0.24626871 |
| 134 | MP0001984_abnormal_olfaction | 0.24546786 |
| 135 | MP0001968_abnormal_touch/_nociception | 0.24162944 |
| 136 | MP0001346_abnormal_lacrimal_gland | 0.23316731 |
| 137 | MP0000372_irregular_coat_pigmentation | 0.23035881 |
| 138 | MP0003938_abnormal_ear_development | 0.21948875 |
| 139 | MP0003795_abnormal_bone_structure | 0.19752888 |
| 140 | MP0003329_amyloid_beta_deposits | 0.19068251 |
| 141 | MP0002971_abnormal_brown_adipose | 0.18722124 |
| 142 | MP0002067_abnormal_sensory_capabilities | 0.18601108 |
| 143 | MP0008569_lethality_at_weaning | 0.17903736 |
| 144 | MP0005197_abnormal_uvea_morphology | 0.16900774 |
| 145 | MP0003953_abnormal_hormone_level | 0.16698958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 8.66084882 |
| 2 | Metabolic alkalosis (HP:0200114) | 8.09024130 |
| 3 | Hypokalemic alkalosis (HP:0001949) | 7.91921764 |
| 4 | Hypomagnesemia (HP:0002917) | 7.60823107 |
| 5 | Hyperactive renin-angiotensin system (HP:0000841) | 7.24133560 |
| 6 | Polyuria (HP:0000103) | 6.95079965 |
| 7 | Abnormality of magnesium homeostasis (HP:0004921) | 6.46966799 |
| 8 | Abnormal urine output (HP:0012590) | 6.45489434 |
| 9 | Abnormality of chloride homeostasis (HP:0011422) | 6.38740978 |
| 10 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 6.09330457 |
| 11 | Abnormality of renal excretion (HP:0011036) | 6.04064149 |
| 12 | Gout (HP:0001997) | 6.01730473 |
| 13 | Abnormal drinking behavior (HP:0030082) | 5.96348502 |
| 14 | Polydipsia (HP:0001959) | 5.96348502 |
| 15 | Tetany (HP:0001281) | 5.78856841 |
| 16 | Abnormality of renin-angiotensin system (HP:0000847) | 5.28348437 |
| 17 | Alkalosis (HP:0001948) | 5.05962116 |
| 18 | Hyperaldosteronism (HP:0000859) | 5.00334779 |
| 19 | Renal salt wasting (HP:0000127) | 4.94033801 |
| 20 | Proximal tubulopathy (HP:0000114) | 4.67034741 |
| 21 | Choroideremia (HP:0001139) | 4.59887919 |
| 22 | Congenital stationary night blindness (HP:0007642) | 4.58795077 |
| 23 | Increased purine levels (HP:0004368) | 4.40782226 |
| 24 | Hyperuricemia (HP:0002149) | 4.40782226 |
| 25 | Scotoma (HP:0000575) | 4.17389945 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.13223189 |
| 27 | Decreased central vision (HP:0007663) | 4.10886309 |
| 28 | Hypercalciuria (HP:0002150) | 4.02616882 |
| 29 | Hyperglycinuria (HP:0003108) | 4.00988740 |
| 30 | Hypokalemia (HP:0002900) | 3.94737172 |
| 31 | Attenuation of retinal blood vessels (HP:0007843) | 3.93623836 |
| 32 | Abnormality of purine metabolism (HP:0004352) | 3.86637240 |
| 33 | Generalized aminoaciduria (HP:0002909) | 3.65190104 |
| 34 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.38076464 |
| 35 | Abnormality of potassium homeostasis (HP:0011042) | 3.33173629 |
| 36 | Abnormality of glycine metabolism (HP:0010895) | 3.32119800 |
| 37 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.32119800 |
| 38 | Renal tubular acidosis (HP:0001947) | 3.29003826 |
| 39 | Abnormality of urine glucose concentration (HP:0011016) | 3.19293726 |
| 40 | Glycosuria (HP:0003076) | 3.19293726 |
| 41 | Confusion (HP:0001289) | 3.16029668 |
| 42 | Ketoacidosis (HP:0001993) | 3.11923173 |
| 43 | Ulnar claw (HP:0001178) | 3.07274806 |
| 44 | Macular degeneration (HP:0000608) | 2.93800297 |
| 45 | Nephrocalcinosis (HP:0000121) | 2.83730976 |
| 46 | Hydroxyprolinuria (HP:0003080) | 2.83524573 |
| 47 | Abnormality of proline metabolism (HP:0010907) | 2.83524573 |
| 48 | Abnormality of the fovea (HP:0000493) | 2.80906204 |
| 49 | Hyperphosphaturia (HP:0003109) | 2.78945439 |
| 50 | Abnormality of nucleobase metabolism (HP:0010932) | 2.75886435 |
| 51 | Ketosis (HP:0001946) | 2.72050786 |
| 52 | Large eyes (HP:0001090) | 2.70918403 |
| 53 | Abnormal urine phosphate concentration (HP:0012599) | 2.70425659 |
| 54 | Delayed epiphyseal ossification (HP:0002663) | 2.68922707 |
| 55 | Hypoglycemic coma (HP:0001325) | 2.64386208 |
| 56 | Delayed CNS myelination (HP:0002188) | 2.57883415 |
| 57 | Peripheral hypomyelination (HP:0007182) | 2.53776949 |
| 58 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.51420192 |
| 59 | Central scotoma (HP:0000603) | 2.50879968 |
| 60 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.48477196 |
| 61 | Action tremor (HP:0002345) | 2.47357367 |
| 62 | Abnormal pupillary function (HP:0007686) | 2.46959471 |
| 63 | Nephrolithiasis (HP:0000787) | 2.43831230 |
| 64 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.39608950 |
| 65 | Adrenal overactivity (HP:0002717) | 2.38971615 |
| 66 | Rickets (HP:0002748) | 2.38806789 |
| 67 | Hypopigmentation of the fundus (HP:0007894) | 2.38084658 |
| 68 | Hypophosphatemia (HP:0002148) | 2.36447470 |
| 69 | Abnormality of macular pigmentation (HP:0008002) | 2.32974551 |
| 70 | Dehydration (HP:0001944) | 2.32428247 |
| 71 | Abnormality of sodium homeostasis (HP:0010931) | 2.29819283 |
| 72 | Hyperglycinemia (HP:0002154) | 2.28068076 |
| 73 | Hypoglycemic seizures (HP:0002173) | 2.28059088 |
| 74 | Increased corneal curvature (HP:0100692) | 2.27683763 |
| 75 | Keratoconus (HP:0000563) | 2.27683763 |
| 76 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.26670637 |
| 77 | Symptomatic seizures (HP:0011145) | 2.26224446 |
| 78 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.25871449 |
| 79 | Lymphangioma (HP:0100764) | 2.22903934 |
| 80 | Hyponatremia (HP:0002902) | 2.20708271 |
| 81 | Widely patent fontanelles and sutures (HP:0004492) | 2.14423692 |
| 82 | Chondrocalcinosis (HP:0000934) | 2.12172807 |
| 83 | Tubular atrophy (HP:0000092) | 2.11457794 |
| 84 | Abnormality of renal resorption (HP:0011038) | 2.10831959 |
| 85 | Enlarged kidneys (HP:0000105) | 2.10329367 |
| 86 | Vascular calcification (HP:0004934) | 2.09809025 |
| 87 | Termporal pattern (HP:0011008) | 2.08888627 |
| 88 | Insidious onset (HP:0003587) | 2.08888627 |
| 89 | Abnormality of Sharpey fibers (HP:0100685) | 2.03578337 |
| 90 | Renal tubular dysfunction (HP:0000124) | 2.01523591 |
| 91 | Systemic lupus erythematosus (HP:0002725) | 1.99607982 |
| 92 | Metaphyseal cupping (HP:0003021) | 1.99571582 |
| 93 | Hyperammonemia (HP:0001987) | 1.97828052 |
| 94 | Decreased circulating renin level (HP:0003351) | 1.97558910 |
| 95 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.93525162 |
| 96 | Tubulointerstitial fibrosis (HP:0005576) | 1.91536842 |
| 97 | Dicarboxylic aciduria (HP:0003215) | 1.88490956 |
| 98 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.88490956 |
| 99 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.86249973 |
| 100 | Metabolic acidosis (HP:0001942) | 1.85804811 |
| 101 | Vomiting (HP:0002013) | 1.85565473 |
| 102 | Vacuolated lymphocytes (HP:0001922) | 1.83364075 |
| 103 | Cardiovascular calcification (HP:0011915) | 1.83335551 |
| 104 | Upper limb muscle weakness (HP:0003484) | 1.82309754 |
| 105 | Paralysis (HP:0003470) | 1.77397665 |
| 106 | Methylmalonic aciduria (HP:0012120) | 1.77164131 |
| 107 | Glomerulosclerosis (HP:0000096) | 1.75102748 |
| 108 | Generalized muscle weakness (HP:0003324) | 1.74937186 |
| 109 | Dyschromatopsia (HP:0007641) | 1.73640481 |
| 110 | Bicornuate uterus (HP:0000813) | 1.70647580 |
| 111 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.68981611 |
| 112 | Potter facies (HP:0002009) | 1.68491029 |
| 113 | Facial shape deformation (HP:0011334) | 1.68491029 |
| 114 | Hypotension (HP:0002615) | 1.68316177 |
| 115 | Increased CSF protein (HP:0002922) | 1.66946148 |
| 116 | Abnormal tarsal ossification (HP:0008369) | 1.66128864 |
| 117 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.65779684 |
| 118 | Nausea (HP:0002018) | 1.64456873 |
| 119 | Abnormal eating behavior (HP:0100738) | 1.64040910 |
| 120 | Hyperventilation (HP:0002883) | 1.62320217 |
| 121 | Hyperkalemia (HP:0002153) | 1.61635262 |
| 122 | Abnormality of the costochondral junction (HP:0000919) | 1.61468361 |
| 123 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.60468216 |
| 124 | Thin bony cortex (HP:0002753) | 1.59262866 |
| 125 | Hypophosphatemic rickets (HP:0004912) | 1.59111109 |
| 126 | Type II diabetes mellitus (HP:0005978) | 1.58565511 |
| 127 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.58128459 |
| 128 | Malnutrition (HP:0004395) | 1.57123274 |
| 129 | Complement deficiency (HP:0004431) | 1.52047513 |
| 130 | Postural tremor (HP:0002174) | 1.46642017 |
| 131 | Impaired proprioception (HP:0010831) | 1.41390571 |
| 132 | Impaired platelet aggregation (HP:0003540) | 1.40395538 |
| 133 | Abnormal platelet function (HP:0011869) | 1.40395538 |
| 134 | Glomerulonephritis (HP:0000099) | 1.40195840 |
| 135 | Pigmentary retinal degeneration (HP:0001146) | 1.40001366 |
| 136 | Progressive sensorineural hearing impairment (HP:0000408) | 1.37090550 |
| 137 | Neonatal onset (HP:0003623) | 1.35920296 |
| 138 | Hypoplasia of the iris (HP:0007676) | 1.35424005 |
| 139 | Cone-rod dystrophy (HP:0000548) | 1.34344858 |
| 140 | Constricted visual fields (HP:0001133) | 1.33661734 |
| 141 | Photophobia (HP:0000613) | 1.27123214 |
| 142 | Chorioretinal atrophy (HP:0000533) | 1.22371552 |
| 143 | Paresthesia (HP:0003401) | 1.22297466 |
| 144 | Nephrogenic diabetes insipidus (HP:0009806) | 1.19385683 |
| 145 | Abnormality of the renal medulla (HP:0100957) | 1.16722042 |
| 146 | White forelock (HP:0002211) | 1.14651057 |
| 147 | Abnormality of complement system (HP:0005339) | 1.12922506 |
| 148 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.12486049 |
| 149 | Esophageal varix (HP:0002040) | 1.02454629 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 8.65692788 |
| 2 | WNK4 | 7.13346626 |
| 3 | OXSR1 | 5.98631681 |
| 4 | WNK3 | 5.72855820 |
| 5 | STK39 | 4.04210475 |
| 6 | KDR | 2.61227402 |
| 7 | GRK1 | 2.30819148 |
| 8 | SGK223 | 1.82129588 |
| 9 | SGK494 | 1.82129588 |
| 10 | INSRR | 1.80856688 |
| 11 | BCKDK | 1.80304579 |
| 12 | CAMK1G | 1.65363247 |
| 13 | WNK1 | 1.55507216 |
| 14 | PDK2 | 1.48855030 |
| 15 | BMX | 1.47373032 |
| 16 | CAMK1D | 1.46698810 |
| 17 | SGK2 | 1.19803037 |
| 18 | TEC | 1.12932916 |
| 19 | TGFBR2 | 1.00515860 |
| 20 | STK38L | 0.98861831 |
| 21 | SGK3 | 0.90821048 |
| 22 | PTK2B | 0.89150492 |
| 23 | TAOK3 | 0.84363330 |
| 24 | STK38 | 0.83396397 |
| 25 | PDK4 | 0.80831096 |
| 26 | PDK3 | 0.80831096 |
| 27 | PINK1 | 0.78139061 |
| 28 | PRKAA2 | 0.75948685 |
| 29 | MAPK15 | 0.73685007 |
| 30 | MST4 | 0.73094722 |
| 31 | EPHA4 | 0.67675632 |
| 32 | EPHA3 | 0.65415718 |
| 33 | MAP2K2 | 0.64858382 |
| 34 | SGK1 | 0.64266112 |
| 35 | TESK2 | 0.62249036 |
| 36 | NUAK1 | 0.58061058 |
| 37 | GSK3A | 0.57014564 |
| 38 | ERN1 | 0.52180220 |
| 39 | MAPK12 | 0.50483273 |
| 40 | IRAK2 | 0.50140398 |
| 41 | PNCK | 0.49678196 |
| 42 | PRKCG | 0.49472208 |
| 43 | PIK3CG | 0.49057680 |
| 44 | AKT3 | 0.48860813 |
| 45 | PRKCE | 0.46614432 |
| 46 | PRKAA1 | 0.46599188 |
| 47 | ADRBK2 | 0.44602167 |
| 48 | PDPK1 | 0.42080210 |
| 49 | NEK6 | 0.41999593 |
| 50 | NEK1 | 0.41531575 |
| 51 | EPHB2 | 0.39627743 |
| 52 | LRRK2 | 0.39504546 |
| 53 | MST1R | 0.38908724 |
| 54 | PAK3 | 0.38530113 |
| 55 | MYLK | 0.36542980 |
| 56 | RIPK4 | 0.35354997 |
| 57 | PTK2 | 0.32914243 |
| 58 | RIPK1 | 0.32703091 |
| 59 | MAPK7 | 0.31747973 |
| 60 | FGFR3 | 0.31328761 |
| 61 | CSNK1A1 | 0.31214163 |
| 62 | PRKD2 | 0.30373841 |
| 63 | CAMK4 | 0.30036202 |
| 64 | MAPK11 | 0.29016987 |
| 65 | IRAK3 | 0.28861218 |
| 66 | NTRK1 | 0.28843245 |
| 67 | NTRK3 | 0.28716947 |
| 68 | TNK2 | 0.28102549 |
| 69 | OBSCN | 0.28006252 |
| 70 | MAP2K1 | 0.27693856 |
| 71 | DDR2 | 0.27238667 |
| 72 | PRKCZ | 0.26941858 |
| 73 | INSR | 0.26688957 |
| 74 | ADRBK1 | 0.26646880 |
| 75 | TSSK6 | 0.26219854 |
| 76 | FER | 0.25594847 |
| 77 | PRKCI | 0.25578635 |
| 78 | GRK5 | 0.25129544 |
| 79 | EPHB1 | 0.24865691 |
| 80 | MINK1 | 0.24030359 |
| 81 | PRKG2 | 0.23573127 |
| 82 | ABL2 | 0.22813912 |
| 83 | DYRK1B | 0.22607302 |
| 84 | STK11 | 0.22428043 |
| 85 | CSK | 0.22256273 |
| 86 | ITK | 0.21876002 |
| 87 | FGFR4 | 0.21838183 |
| 88 | PRKCH | 0.21378395 |
| 89 | PRKCA | 0.20691566 |
| 90 | IRAK1 | 0.20382439 |
| 91 | FGR | 0.20141100 |
| 92 | NTRK2 | 0.19981537 |
| 93 | AKT2 | 0.19979429 |
| 94 | FRK | 0.19810719 |
| 95 | FES | 0.19668560 |
| 96 | PRKCB | 0.19451170 |
| 97 | PAK4 | 0.19422934 |
| 98 | SRC | 0.19396222 |
| 99 | MAP3K12 | 0.19303171 |
| 100 | IGF1R | 0.19092033 |
| 101 | MET | 0.18889023 |
| 102 | PRKCD | 0.18444846 |
| 103 | NLK | 0.17530373 |
| 104 | TTN | 0.17523517 |
| 105 | CAMK1 | 0.17426341 |
| 106 | PRKACG | 0.17257056 |
| 107 | CCNB1 | 0.16769320 |
| 108 | MAP4K1 | 0.15604767 |
| 109 | MAP3K7 | 0.15426048 |
| 110 | MAP3K11 | 0.15332820 |
| 111 | SCYL2 | 0.15297449 |
| 112 | EGFR | 0.15109592 |
| 113 | PTK6 | 0.14582790 |
| 114 | TGFBR1 | 0.14445616 |
| 115 | BTK | 0.14371444 |
| 116 | CDK12 | 0.13507008 |
| 117 | ZAP70 | 0.13475751 |
| 118 | GRK6 | 0.13379850 |
| 119 | CAMKK2 | 0.13244594 |
| 120 | CDK5 | 0.12754410 |
| 121 | PRKACA | 0.12247295 |
| 122 | MAP3K3 | 0.12115238 |
| 123 | MAP3K1 | 0.11515819 |
| 124 | SYK | 0.11420231 |
| 125 | PRKD1 | 0.11163842 |
| 126 | JAK1 | 0.10033390 |
| 127 | CSNK1D | 0.09649241 |
| 128 | PAK6 | 0.09529054 |
| 129 | CAMK2B | 0.09383444 |
| 130 | MAP3K13 | 0.09020138 |
| 131 | ROCK1 | 0.08998986 |
| 132 | ACVR1B | 0.08503614 |
| 133 | ICK | 0.07898887 |
| 134 | PDK1 | 0.07874382 |
| 135 | TRPM7 | 0.07671006 |
| 136 | MAP3K2 | 0.07663048 |
| 137 | PIK3CA | 0.07580726 |
| 138 | KIT | 0.06796139 |
| 139 | RET | 0.06023146 |
| 140 | HIPK2 | 0.05935478 |
| 141 | MAPKAPK3 | 0.05299307 |
| 142 | CAMK2A | 0.05199182 |
| 143 | MAPK3 | 0.04985988 |
| 144 | TESK1 | 0.04605800 |
| 145 | MARK3 | 0.03799897 |
| 146 | RPS6KA3 | 0.03183341 |
| 147 | STK3 | 0.02750571 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 6.77758395 |
| 2 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.67719650 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.40922783 |
| 4 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.23483511 |
| 5 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.15731680 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.87450510 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.84065811 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.82733613 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.82625314 |
| 10 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.68905055 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.43802275 |
| 12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.29196935 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.20403439 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.07985132 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.02618230 |
| 16 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.99137076 |
| 17 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.98445745 |
| 18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.96626831 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.94508081 |
| 20 | * Bile secretion_Homo sapiens_hsa04976 | 1.91883280 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.90727097 |
| 22 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.88334443 |
| 23 | Mineral absorption_Homo sapiens_hsa04978 | 1.84072518 |
| 24 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.80516101 |
| 25 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.75731732 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.69210484 |
| 27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.65536445 |
| 28 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.58798692 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.45033191 |
| 30 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.40936728 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.35771371 |
| 32 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.34017021 |
| 33 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.31040650 |
| 34 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.26630612 |
| 35 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.26131928 |
| 36 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.23269403 |
| 37 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.18886040 |
| 38 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.14337111 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.12745293 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.11759912 |
| 41 | Carbon metabolism_Homo sapiens_hsa01200 | 1.09360068 |
| 42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.00683198 |
| 43 | Other glycan degradation_Homo sapiens_hsa00511 | 1.00145875 |
| 44 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.96843690 |
| 45 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.92355432 |
| 46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.90676243 |
| 47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90493087 |
| 48 | Histidine metabolism_Homo sapiens_hsa00340 | 0.89970837 |
| 49 | Lysine degradation_Homo sapiens_hsa00310 | 0.89249760 |
| 50 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.89178558 |
| 51 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.89169736 |
| 52 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.88280803 |
| 53 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.84105083 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.82432329 |
| 55 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.82056124 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.81030947 |
| 57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78611949 |
| 58 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.75474085 |
| 59 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.74753003 |
| 60 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.71433357 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62888051 |
| 62 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60799706 |
| 63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.60577384 |
| 64 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59881191 |
| 65 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57279689 |
| 66 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.55777643 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55184923 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 0.54153262 |
| 69 | Melanoma_Homo sapiens_hsa05218 | 0.53352947 |
| 70 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.52809227 |
| 71 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.50520548 |
| 72 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.50472038 |
| 73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50087350 |
| 74 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.49898051 |
| 75 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49754724 |
| 76 | Glioma_Homo sapiens_hsa05214 | 0.49727558 |
| 77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46167065 |
| 78 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.45842400 |
| 79 | GABAergic synapse_Homo sapiens_hsa04727 | 0.45255085 |
| 80 | Salivary secretion_Homo sapiens_hsa04970 | 0.44999665 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44728422 |
| 82 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43227940 |
| 83 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42198215 |
| 84 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.41824176 |
| 85 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41053476 |
| 86 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.40864859 |
| 87 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40835513 |
| 88 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.40265111 |
| 89 | Prion diseases_Homo sapiens_hsa05020 | 0.39742981 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.39652748 |
| 91 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38883357 |
| 92 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.38576708 |
| 93 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.38245424 |
| 94 | Insulin secretion_Homo sapiens_hsa04911 | 0.35520194 |
| 95 | Adherens junction_Homo sapiens_hsa04520 | 0.34050828 |
| 96 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.33950139 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.33698418 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.33585031 |
| 99 | Bladder cancer_Homo sapiens_hsa05219 | 0.32771363 |
| 100 | Circadian entrainment_Homo sapiens_hsa04713 | 0.32549788 |
| 101 | Morphine addiction_Homo sapiens_hsa05032 | 0.31264301 |
| 102 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.31161472 |
| 103 | Lysosome_Homo sapiens_hsa04142 | 0.30372259 |
| 104 | Pertussis_Homo sapiens_hsa05133 | 0.30221501 |
| 105 | Endometrial cancer_Homo sapiens_hsa05213 | 0.30049266 |
| 106 | Renin secretion_Homo sapiens_hsa04924 | 0.29758180 |
| 107 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.29756591 |
| 108 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29374845 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.27409941 |
| 110 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.26883848 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26607002 |
| 112 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.26474377 |
| 113 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.26083666 |
| 114 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.25658584 |
| 115 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.24947562 |
| 116 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.24838507 |
| 117 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.23060895 |
| 118 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.22804501 |
| 119 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.21599876 |
| 120 | Retinol metabolism_Homo sapiens_hsa00830 | 0.21547952 |
| 121 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.21258477 |
| 122 | Tight junction_Homo sapiens_hsa04530 | 0.21233281 |
| 123 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.20582821 |
| 124 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.20328296 |
| 125 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.19364345 |
| 126 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.19350867 |
| 127 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.18936711 |
| 128 | Taste transduction_Homo sapiens_hsa04742 | 0.18830252 |
| 129 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.18822981 |
| 130 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.18244012 |
| 131 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.17546385 |
| 132 | Gap junction_Homo sapiens_hsa04540 | 0.17428882 |
| 133 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.16742761 |
| 134 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.16356381 |
| 135 | Focal adhesion_Homo sapiens_hsa04510 | 0.16152407 |

